Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

By M. Roh, L. Colangelo, M. O’connell, G. Yothers, M. Deutsch, C. Allegra, M. Kahlenberg, Luis Baez-Diaz, Carol S Ursiny, N. Petrelli and 1 more. Journal of Clinical Oncology, 2009

905 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/274ebaa4559e0d03f5af75d24641ee8dec09d859

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Wittekind
2. Mariel Villanueva
3. S. Merkel
4. T. Beissbarth
5. H. Witzigmann
6. Purvesh Khatri
7. Tala Bakheet
8. Thomas Breslin

Citations in the corpus

• Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. (2012, positive): “4 years, this trial showed a significantly improved disease-free survival and a trend toward improved overall survival in the preoperative CRT arm; however, there was no improvement in local control.(4) The German study was completed, and 5-year results were reported in 2004.”